Literature DB >> 22837318

Microbial dysbiosis in pediatric patients with Crohn's disease.

Nadeem O Kaakoush1, Andrew S Day, Karina D Huinao, Steven T Leach, Daniel A Lemberg, Scot E Dowd, Hazel M Mitchell.   

Abstract

Microbial dysbiosis has been suggested to be involved in the pathogenesis of Crohn's disease (CD); however, many studies of gut microbial communities have been confounded by environmental and patient-related factors. In this study, the microbial flora of fecal samples from 19 children newly diagnosed with CD and 21 age-matched controls were analyzed using high-throughput sequencing to determine differences in the microbial composition between CD patients and controls. Analysis of the microbial composition of specific bacterial groups revealed that Firmicutes percentages were significantly lower in CD patients than in controls and that this was due largely to changes in the class Clostridia. Bacteroidetes and Proteobacteria percentages were higher and significantly higher in CD patients than in controls, respectively. Both the detection frequencies of Bacteroidetes and Firmicutes correlated (positively and negatively, respectively) with the calculated pediatric Crohn's disease activity index scores of patients. Upon further analysis, differences in the microbial compositions of patients with mild disease and moderate to severe disease were identified. Our findings indicate that a combination of different bacterial species or a dynamic interplay between individual species is important for disease and is consistent with the dysbiosis hypothesis of CD.

Entities:  

Mesh:

Year:  2012        PMID: 22837318      PMCID: PMC3457451          DOI: 10.1128/JCM.01396-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  53 in total

1.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

2.  Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study.

Authors:  Susanne Mueller; Katiana Saunier; Christiana Hanisch; Elisabeth Norin; Livia Alm; Tore Midtvedt; Alberto Cresci; Stefania Silvi; Carla Orpianesi; Maria Cristina Verdenelli; Thomas Clavel; Corinna Koebnick; Hans-Joachim Franz Zunft; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

3.  Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.

Authors:  Jeffrey Hyams; James Markowitz; Anthony Otley; Joel Rosh; David Mack; Athos Bousvaros; Subra Kugathasan; M Pfefferkorn; Vasundhara Tolia; Jonathan Evans; William Treem; Robert Wyllie; Robert Rothbaum; J del Rosario; Aubrey Katz; Adam Mezoff; M Oliva-Hemker; Trudy Lerer; Anne Griffiths
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-10       Impact factor: 2.839

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles.

Authors:  Johan Dicksved; Helen Flöistrup; Anna Bergström; Magnus Rosenquist; Göran Pershagen; Annika Scheynius; Stefan Roos; Johan S Alm; Lars Engstrand; Charlotte Braun-Fahrländer; Erika von Mutius; Janet K Jansson
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

Review 6.  The role of bacteria and pattern-recognition receptors in Crohn's disease.

Authors:  Si Ming Man; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

7.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.

Authors:  Julien Loubinoux; Jean-Pierre Bronowicki; Ines A C Pereira; Jean-Louis Mougenel; Alain E Faou
Journal:  FEMS Microbiol Ecol       Date:  2002-05-01       Impact factor: 4.194

8.  Experimental exposure of zebrafish, Danio rerio (Hamilton), to Mycobacterium marinum and Mycobacterium peregrinum reveals the gastrointestinal tract as the primary route of infection: a potential model for environmental mycobacterial infection.

Authors:  M J Harriff; L E Bermudez; M L Kent
Journal:  J Fish Dis       Date:  2007-10       Impact factor: 2.767

9.  Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies.

Authors:  D J Brenner; D G Hollis; C W Moss; C K English; G S Hall; J Vincent; J Radosevic; K A Birkness; W F Bibb; F D Quinn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP).

Authors:  Scot E Dowd; Todd R Callaway; Randall D Wolcott; Yan Sun; Trevor McKeehan; Robert G Hagevoort; Thomas S Edrington
Journal:  BMC Microbiol       Date:  2008-07-24       Impact factor: 3.605

View more
  49 in total

1.  Molecular characterization of skin microbiota between cancer cachexia patients and healthy volunteers.

Authors:  Wei Li; Lei Han; Pengbo Yu; Chaofeng Ma; Xiaokang Wu; John E Moore; Jiru Xu
Journal:  Microb Ecol       Date:  2014-01-09       Impact factor: 4.552

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Gut microbiota and hematopoietic stem cell transplantation: where do we stand?

Authors:  D Zama; E Biagi; R Masetti; P Gasperini; A Prete; M Candela; P Brigidi; A Pession
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

4.  Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome.

Authors:  Nicolaas H Fourie; Dan Wang; Sarah K Abey; Amy L Creekmore; Shuangsong Hong; Christiana G Martin; John W Wiley; Wendy A Henderson
Journal:  Gut Microbes       Date:  2017-01-06

Review 5.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 6.  Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.

Authors:  Rok Orel; Tina Kamhi Trop
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.

Authors:  Lee D Chaves; Daniel I McSkimming; Mark A Bryniarski; Amanda M Honan; Sham Abyad; Shruthi A Thomas; Steven Wells; Michael Buck; Yijun Sun; Robert J Genco; Richard J Quigg; Rabi Yacoub
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-25

8.  The treatment-naive microbiome in new-onset Crohn's disease.

Authors:  Subra Kugathasan; Lee A Denson; Dirk Gevers; Yoshiki Vázquez-Baeza; Will Van Treuren; Boyu Ren; Emma Schwager; Dan Knights; Se Jin Song; Moran Yassour; Xochitl C Morgan; Aleksandar D Kostic; Chengwei Luo; Antonio González; Daniel McDonald; Yael Haberman; Thomas Walters; Susan Baker; Joel Rosh; Michael Stephens; Melvin Heyman; James Markowitz; Robert Baldassano; Anne Griffiths; Francisco Sylvester; David Mack; Sandra Kim; Wallace Crandall; Jeffrey Hyams; Curtis Huttenhower; Rob Knight; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

9.  Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.

Authors:  Fatouma Salem; Nadège Kindt; Julian R Marchesi; Patrick Netter; Anthony Lopez; Tunay Kokten; Silvio Danese; Jean-Yves Jouzeau; Laurent Peyrin-Biroulet; David Moulin
Journal:  United European Gastroenterol J       Date:  2019-08-01       Impact factor: 4.623

10.  Angiogenin maintains gut microbe homeostasis by balancing α-Proteobacteria and Lachnospiraceae.

Authors:  Desen Sun; Rongpan Bai; Wei Zhou; Zhengrong Yao; Yaxin Liu; Shasha Tang; Xiaolong Ge; Liang Luo; Chi Luo; Guo-Fu Hu; Jinghao Sheng; Zhengping Xu
Journal:  Gut       Date:  2020-08-25       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.